FDA reports liver failure in patient taking Eli Lilly’s Foundayo

The Food and Drug Administration has recorded two ‘serious’ cases in patients taking Eli Lilly’s weight-loss pill.

Eli Lilly stock swings after FDA liver failure report for GLP-1 drug

Eli Lilly has had a rough start to the year. Things nearly took a turn for the worse after this breaking news.
BioSpace

Foundayo’s liver failure blip weighs down Lilly shares but analysts unconcerned

The selloff in Eli Lilly's shares was “overdone,” according to RBC Capital Markets, which noted that the overall safety ...

Eli Lilly Balances Foundayo Safety Concerns With Record US$4.5b Expansion

Eli Lilly's new oral weight loss drug Foundayo is under scrutiny after an FDA-reported case of liver failure and other ...
Blockonomi

Eli Lilly (LLY) Stock Dips on Foundayo Liver Safety Concerns: Should You Buy?

Eli Lilly (LLY) stock dropped 3% on Foundayo liver concerns. Analysts say the decline is overdone and recommend buying the ...

Eli Lilly stock slips on safety concerns around new pill

Eli Lilly is seeing its stock come under pressure after a report linked a case of liver failure to its newly launched weight loss pill Fo ...

Eli Lilly’s Dividend Hike Gets Lost in the Noise Over a Single Liver Case

A solitary entry in a federal adverse-event database was enough to knock nearly $15 off Eli Lilly’s share price on Monday, but the selloff proved fleeting. Within hours, the stock had clawed back into ...

Truist Reaffirms Buy on Eli Lilly (LLY) After Trial Success

Eli Lilly & Company (NYSE:LLY) ranks among the stocks to invest in before they split next. Truist Securities restated its Buy ...
Wall Street Journal

Liver Disease Biotechs’ Stocks Crash on Eli Lilly’s Mounjaro Data

A clinical trial result presented almost as an aside in Eli Lilly’s latest earnings report dropped like a bomb this week on the biotechs developing treatments for the liver condition known as MASH.